Preeclampsia: risk factors, diagnosis, management, and the cardiovascular impact on the offspring

R Fox, J Kitt, P Leeson, CYL Aye… - Journal of clinical …, 2019 - mdpi.com
Hypertensive disorders of pregnancy affect up to 10% of pregnancies worldwide, which
includes the 3%–5% of all pregnancies complicated by preeclampsia. Preeclampsia is …

Update on the diagnosis and classification of fetal growth restriction and proposal of a stage-based management protocol

F Figueras, E Gratacós - Fetal diagnosis and therapy, 2014 - karger.com
Small fetuses are defined as those with an ultrasound estimated weight below a threshold,
most commonly the 10th centile. The first clinically relevant step is the distinction of 'true'fetal …

[PDF][PDF] ISUOG Practice Guidelines: diagnosis and management of small-for-gestational-age fetus and fetal growth restriction

CC Lees, T Stampalija, AA Baschat… - Ultrasound in Obstetrics …, 2020 - arts.units.it
The International Society of Ultrasound in Obstetrics and Gynecology (ISUOG) is a scientific
organization that encourages sound clinical practice, and high-quality teaching and …

[HTML][HTML] FIGO (international Federation of Gynecology and obstetrics) initiative on fetal growth: best practice advice for screening, diagnosis, and management of fetal …

N Melamed, A Baschat, Y Yinon… - … of Gynaecology and …, 2021 - ncbi.nlm.nih.gov
Fetal growth restriction (FGR) is defined as the failure of the fetus to meet its growth potential
due to a pathological factor, most commonly placental dysfunction. Worldwide, FGR is a …

Society for Maternal-Fetal Medicine Consult Series# 52: diagnosis and management of fetal growth restriction:(replaces clinical guideline number 3, April 2012)

JG Martins, JR Biggio, A Abuhamad… - American journal of …, 2020 - Elsevier
Fetal growth restriction can result from a variety of maternal, fetal, and placental conditions. It
occurs in up to 10% of pregnancies and is a leading cause of infant morbidity and mortality …

CONSORT statement for randomized trials of nonpharmacologic treatments: a 2017 update and a CONSORT extension for nonpharmacologic trial abstracts

I Boutron, DG Altman, D Moher, KF Schulz… - Annals of internal …, 2017 - acpjournals.org
Incomplete and inadequate reporting is an avoidable waste that reduces the usefulness of
research. The CONSORT (Consolidated Standards of Reporting Trials) Statement is an …

2 year neurodevelopmental and intermediate perinatal outcomes in infants with very preterm fetal growth restriction (TRUFFLE): a randomised trial

CC Lees, N Marlow, A van Wassenaer-Leemhuis… - The Lancet, 2015 - thelancet.com
Background No consensus exists for the best way to monitor and when to trigger delivery in
mothers of babies with fetal growth restriction. We aimed to assess whether changes in the …

Perinatal morbidity and mortality in early‐onset fetal growth restriction: cohort outcomes of the trial of randomized umbilical and fetal flow in Europe (TRUFFLE)

C Lees, N Marlow, B Arabin, CM Bilardo… - … in obstetrics & …, 2013 - Wiley Online Library
Objectives Few data exist for counseling and perinatal management of women after an
antenatal diagnosis of early‐onset fetal growth restriction. Yet, the consequences of preterm …

Screening for fetal growth restriction and placental insufficiency

MC Audette, JC Kingdom - Seminars in Fetal and Neonatal Medicine, 2018 - Elsevier
Fetal growth restriction (FGR) continues to be a leading cause of preventable stillbirth and
poor neurodevelopmental outcomes in offspring, and furthermore is strongly associated with …

An integrated approach to fetal growth restriction

F Figueras, E Gratacos - Best practice & research Clinical obstetrics & …, 2017 - Elsevier
Highlights•Management of FGR is challenging because not all small fetuses are true forms
of growth restriction and clinical presentation is variable.•Doppler is the central tool for …